In the present study, we have demonstrated that suppression of duplication-mediated GCRs by
RAD6 is epistatic to the replication stress checkpoint and that the
RAD18-,
RAD5-,
UBC13-, and
MMS2-dependent error-free PRR pathway is the
RAD6-dependent pathway that is primarily responsible for suppressing duplication-mediated GCRs. The translesion polymerase-dependent pathways for PRR and the
BRE1- and
UBR1-dependent
RAD6 pathways played small roles in suppressing duplication-mediated GCRs. In addition, genes that are not typically considered as encoding components of the PRR pathways, but which have been implicated in PRR by a few genetic studies, including
RAD9 [53] and
TAF14 (
ANC1)
[41], as well as the Shu complex genes,
PSY3 and
CSM2, implicated as acting downstream of
RAD5 [54], did not appear to play significant roles in suppressing duplication-mediated GCRs ( & , and not shown). The suppression of duplication-mediated GCRs exhibited remarkably complex genetic interactions between downstream PRR components (), involved the helicase and not the RING-finger functions of Rad5, and required Sgs1 for processing of repair intermediates. Our analysis using the sensitive duplication-mediated GCR assay revealed a number of surprising results that appear paradoxical in the context of commonly accepted models for PRR
[4], but fit with a growing body of evidence that indicate that the
in vivo pathways are more complicated than can be accounted for by present models
[26],
[45]–
[47],
[55]–
[57].
The first surprising result is the lack of epistasis between
RAD5 and
UBC13 in the duplication-mediated GCR assay, as the Ubc13-Mms2 synthesis of Lys63-linked polyubiquitin chains on PCNA is dependent upon the E3 function of Rad5
[21],
[57]. This lack of epistasis is consistent with a function of Rad5 that is independent of PCNA polyubiquitination, consistent with our observation of weak defects caused by mutations affecting the Rad5 RING finger function but large defects caused by mutations affecting the Rad5 helicase function, and consistent with a role of Rad5 in some translesion polymerase-dependent events
[45],
[46] and the ability of Rad5 to recognize and bind PCNA with a similar affinity regardless of its ubiquitination status
[57]. This lack of epistasis also argues for a role of Ubc13 independent of Rad5 that would not have been predicted by the lesser sensitivity of
UBC13 and
MMS2 mutants to DNA damaging agents than seen with
rad5 mutants
[45],
[47], and may reconcile the weak effect of the Rad5 RING finger mutation in the duplication-mediated GCR assay with the stronger effect of the
ubc13Δ mutation. Together with the observation that a
rev3Δ mutation shows synergistic interactions with both
rad5Δ and
ubc13Δ mutations in the duplication-mediated GCR assay, this supports the idea that there are individual pathways that repair spontaneous damage that are solely dependent upon
REV3,
RAD5 or
UBC13 in addition to pathways that are dependent upon combinations of these genes (); in the context of this model, the rates of duplication-mediated GCRs seen in different mutants suggest that
UBC13 and
RAD5 function in the same pathway more frequently than other combinations in accord with more simple models of “error-free” and “error-prone” branches
[4].
The second surprising result from our studies is the fact that the increased duplication-mediated GCR rate caused by the
rad5Δ mutation was not affected by a deletion of
SIZ1 but the
rad5Δ mutation was epistatic to both a deletion of
SRS2 and the
pol30-119 mutation in the duplication-mediated GCR assay. The
SRS2 gene was originally identified through the isolation of a mutation that suppressed the trimethoprim- and UV-sensitive phenotypes of
rad6Δ and
rad18Δ mutants
[36] where HR was required for suppression
[58]. Epistasis of a
rad5Δ mutation with a
srs2Δ mutation is consistent with previous observations of a requirement for
SRS2 for
RAD5-dependent error-free PRR
[51], and could be due to direct recruitment of Rad5 to the site of DNA damage by Srs2 or indirect recruitment via a role of Srs2 in suppressing HR
[59],
[60]. Our results are not consistent, however, with an absolute requirement of Siz1-mediated PCNA sumoylation and subsequent Srs2 recruitment for Srs2 function to suppress duplication-mediated GCRs. For example, a
srs2Δ mutation caused a greater GCR rate in the duplication-mediated GCR assay than a
siz1Δ mutation and was strongly epistatic to PRR gene deletions, which is consistent with previously published results that an
srs2Δ mutation causes a greater suppression of the DNA damaging agent sensitivity caused by a
rad6Δ mutation than the level of suppression caused by a
siz1Δ mutation
[34]. The observation of Cdk1- and PCNA-independent roles of Srs2 in the completion of synthesis-dependent strand annealing
[56] is also consistent with a Siz1-independent role of Srs2. However, this contrasts with suggestions of
SIZ1-dependence of PRR based on genetic interactions between
siz1Δ and
rad18Δ mutations
[8],
[34].
The third surprising result from our studies is the synergistic interaction between the deletion of
RAD6 and the deletion of
RAD5 in the duplication-mediated GCR assay, as Rad5 is typically considered to function downstream of Rad6-Rad18-mediated monoubiquitination of PCNA at Lys163
[4],
[17]. This result is even more surprising given the equivalent duplication-mediated GCR rates observed in
rad6Δ,
rad18Δ,
pol30-119, and
rad6Δ pol30-119 mutants and the apparent epistasis of
rad5Δ and
pol30-119 mutations in the duplication-mediated GCR assay. The epistasis of
pol30-119, but not
rad6Δ, to
rad5Δ, and the lack of effect of combining
siz1Δ and
rad5Δ mutations are inconsistent with models suggesting Rad6-dependent monoubiquition of PCNA at Lys164 is absolutely required for Rad5 function. However, these results are consistent with the possibility that ubiquitin ligases other than Rad6 can modify Lys164 of PCNA
in vivo, which has been observed to occur at low levels in
rad6Δ mutants
[26].
Extensive pathway analysis has led to the hypothesis that replication errors are a major form of spontaneous DNA damage giving rise to duplication-mediated GCRs
[27]. Thus, the apparent epistasis of
RAD6 to components of the replication stress checkpoint suggests that maintaining appropriate DNA structures at the replication checkpoint
[61],
[62] is important for the PRR pathway to suppress duplication-mediated GCRs, and might be required for PRR to repair replication damage via template-switching pathways
[6]–
[10], which likely operates in competition with other pathways that might excise such DNA damage
[5],
[45]. Generation of potential template-switched products by the Rad5 helicase activity would produce molecules requiring further processing. We found that a
rad5Δ mutation partially suppressed the defects of the
sgs1Δ mutation, potentially suggesting that
RAD5-dependent DNA structures that lead to GCRs accumulate in
sgs1Δ mutants. This idea is consistent with the observation of HR-dependent DNA intermediates in
sgs1Δ strains that accumulate in a
RAD5-dependent manner
[8] and the observed patterns of sensitivity to DNA damaging agents caused by different combinations of
sgs1Δ,
mms2Δ, and
pol30-119 mutations
[8],
[54]. This observed partial epistasis is also consistent with the ability of
SGS1 and its human homolog
BLM to unwind Holliday junctions and other branched DNA structures
[63]–
[66] and resolve double-Holliday junctions
[67]. Interestingly, we also found that
srs2Δ and
hcs1Δ mutations were epistatic to a
rad5Δ mutation suggesting that the Srs2 and Hcs1 helicases may also act in processing stalled replication forks.
Our data suggest how PRR defects cause increased rates of duplication-mediated GCRs, but not single-copy sequence mediated-GCRs, yet suppress the increased rates of single-copy sequence-mediated GCRs caused by mutations in genes such as
ASF1 [26],
PIF1 (
[25], ) and
RAD53 () (). These phenotypes are not simply a matter of PRR mutants having a hyperrecombination phenotype
[23],
[68], as other hyperrecombination mutants, such as
rad27Δ [69],
[70] and
mre11Δ,
rad50Δ and
xrs2Δ mutants
[71]–
[74] have increased rates of both single-copy sequence- and duplication-mediated GCRs
[27],
[75] and likely have an increased basal level of spontaneous DNA damage. Rather, PRR must function either by preventing damage from becoming HR substrates () or as an alternative pathway to HR in the processing of damage (). PRR defects would thus increase the potential for HR, increasing the rate of duplication-mediated GCRs resulting from non-allelic HR while having little affect or even suppressing the rate of single-copy sequence-mediated GCRs as increased allelic HR acts on single-copy sequences to suppress GCRs
[25],
[26]. These models are consistent with the synergisitic effects of deleting
RAD5 or
RAD18 in conjunction with deleting
RAD52 on the rate of single copy sequence-mediated GCRs as well as the decreased rates of duplication-mediated GCRs caused by deleting
RAD52 in PRR mutants. Moreover, an additional role of PRR is suggested by the fact that PRR defective mutations also suppress the high rate of single copy sequence-mediated GCRs caused by different mutations. This additional role could be indirectly or directly suppressing HR, such as by controlling the nature of damaged DNA or by the Srs2-mediated suppression of Rad51 filaments
[59],
[60]. Alternatively, this additional function of PRR could promote the processing of DNA damage by non-HR mediated mechanisms like non-homologous end-joining (NHEJ) or chromosome healing by
de novo telomere addition
[43],
[44]. We note that the generality of PRR defective mutations in suppressing the increased rates of single copy sequence-mediated GCRs caused by different mutations has not yet been broadly established; in addition,
RAD5 has been reported to suppress NHEJ
[76]. The role of PRR in specifically suppressing duplication-mediated GCRs suggests that PRR plays critical roles in suppressing non-allelic HR in genomes containing high levels of duplicated sequences. In humans, suppression of non-allelic HR is likely important for preventing genome rearrangements from occurring due to the large numbers of duplicated sequences in the human genome
[77],
[78] and to suppress copy number variations that contribute to human genetic variation and genetic disease
[79],
[80].